UNITEDHEALTH GROUP INC director Michele J. Hooper received 292 shares of common stock as dividend equivalents on vested deferred stock units. These dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units, meaning they function as routine, compensation-related accruals rather than an open-market purchase. After this acquisition, Hooper directly holds a total of 41,586 shares of UnitedHealth Group common stock, indicating this is a small, incremental increase to an existing position.
UNITEDHEALTH GROUP INC director Kristen Gil reported a small stock award. On March 17, 2026, Gil acquired 8 shares of common stock at $0.00 per share, described as dividend equivalents paid on vested deferred stock units and subject to the same terms as those units. After this award, Gil holds 2,083 shares directly and 3,800 shares indirectly through a trust, indicating this is a routine, compensation-related update rather than an open-market trade.
UNITEDHEALTH GROUP INC director Scott Gottlieb reported a small compensation-related equity acquisition. He received 1 share-equivalent of common stock on 2026-03-17 as dividend equivalents paid on vested deferred stock units, which are immediately vested and follow the same terms as the underlying units. After this award, he directly owns 126 shares of common stock.
Conway Patrick Hugh reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC reported that Patrick Hugh Conway, Chief Executive Officer of Optum, received a grant of 125.021 shares of common stock on March 17, 2026 at a price of $0.00 per share. These shares represent dividend equivalents on his outstanding restricted stock units and will vest or be forfeited under the same conditions as those units. Following this award, his directly held common stock position increased to 18,604.991 shares, indicating a routine, compensation-related adjustment rather than an open-market purchase.
UNITEDHEALTH GROUP INC Chief Accounting Officer Dennis Andrew Stankiewicz filed an initial ownership report showing direct holdings of common stock and several grants of non-qualified stock options. He holds 10,137.881 shares of common stock and multiple option awards with exercise prices between $252.37 and $521.97 expiring from 2030 through 2036, many vesting in annual installments.
UnitedHealth Group Incorporated announced that senior leaders will participate in a question-and-answer interview at the Barclays 28th Annual Global Healthcare Conference. They plan to discuss the company’s strategy, market positions, recent results and expectations for its end markets. A live audio webcast will be available through the investor relations section of the company’s website.
UnitedHealth Group Incorporated filed a Form S-3 shelf registration dated March 2, 2026 to register a range of securities, including debt securities, preferred stock, common stock, warrants and guarantees for offerings from time to time after the effective date. The prospectus explains offering mechanics and distribution methods. As context, 907,675,839 shares of common stock were outstanding as of February 20, 2026.
UnitedHealth Group Incorporated has appointed Dennis Stankiewicz, age 48, as Chief Accounting Officer effective March 2, 2026. He will also continue serving as Corporate Controller, a role he has held since April 17, 2023, after joining the company in 2016 as General Auditor.
His compensation includes a $550,000 annual base salary, an initial annual cash bonus target of 85% of base salary, and eligibility for annual and long-term stock-based awards consistent with his seniority. He will receive severance equal to one times base salary if terminated without cause, conditioned on a non-compete during the severance period. The company states he has no related-party transactions requiring disclosure, while current Chief Accounting Officer Tom Roos will become Chief Financial Officer of Optum Insight on March 2, 2026.
UnitedHealth Group is a large, diversified health care and well-being company built around two complementary businesses: Optum and UnitedHealthcare. It is listed on the New York Stock Exchange under the symbol UNH and had 907,675,839 common shares outstanding as of February 20, 2026.
Optum combines Optum Health, Optum Insight and Optum Rx, delivering value-based care, analytics and pharmacy services. In 2025, Optum Rx managed $188 billion in pharmaceutical spending, while Optum Insight reported an aggregate backlog of $31.1 billion, with $18.3 billion expected within 12 months.
UnitedHealthcare provides health benefits to employers, individuals, Medicare and Medicaid beneficiaries, serving tens of millions of people across its Employer & Individual, Medicare & Retirement and Community & State lines. Premium revenues from risk-based products represent nearly 80% of total consolidated revenues, and CMS premium revenues account for 44%. The company employs more than 390,000 people, including nearly 165,000 clinical professionals, and operates under extensive U.S. and international health care, privacy, banking and consumer protection regulations, with detailed risk factors around medical cost trends, technology, cyber security, regulation and competition.
UNITEDHEALTH GROUP INC Chief Accounting Officer Thomas E. Roos reported several equity-related transactions on common stock and options. He was granted 9,768 non-qualified stock options with an exercise right to buy shares, all recorded at a price of $0.0000 per option. He also acquired 2,436 shares of common stock through a grant or award and had 151.777 shares of common stock disposed of to cover tax obligations at $282.3400 per share. Following these transactions, his directly held common stock position increased to 31,283.641 shares. The non-qualified stock options vest 25% each year on February 23 from 2027 through 2030, and restricted stock units referenced in the footnotes vest on the same schedule.